NCT00299676
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Auckland, Australia
- Christchurch Nz, Australia
- Hamilton, Australia
- Porirua, Australia
Clinical trial condition
Explore clinical trials studying Galantamine. Study availability and eligibility vary by location and protocol.
NCT00299676